Evaluation of the T cell and B cell response following the administration of COVID-19 vaccines in Korea
Open Access
- 28 September 2022
- journal article
- research article
- Published by Elsevier BV in Journal of Microbiology, Immunology and Infection
- Vol. 55 (6), 1013-1024
- https://doi.org/10.1016/j.jmii.2022.09.004
Abstract
No abstract availableKeywords
Funding Information
- Korea Health Industry Development Institute (HI20C2027)
- Korea Research Institute of Bioscience and Biotechnology (1711134081)
- National Research Foundation of Korea (2021M3E5E3080379, NRF-2021M3E5E3080382, NRF-2021R1I1A3044483)
This publication has 44 references indexed in Scilit:
- Zoonotic Diseases: Etiology, Impact, and ControlMicroorganisms, 2020
- A comparative overview of COVID-19, MERS and SARS: Review articleInternational Journal of Surgery, 2020
- A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interactionNature Biotechnology, 2020
- Medidas de distanciamento social no controle da pandemia de COVID-19: potenciais impactos e desafios no BrasilCiencia & Saude Coletiva, 2020
- Immunopathological characteristics of coronavirus disease 2019 cases in Guangzhou, ChinaImmunology, 2020
- COVID-19 and social distancingJournal of Public Health, 2020
- Structural and Functional Basis of SARS-CoV-2 Entry by Using Human ACE2Cell, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Vaccine-induced antigen-specific regulatory T cells attenuate the antiviral immunity against acute influenza virus infectionMucosal Immunology, 2018
- Regulatory T cell frequencies and phenotypes following anti-viral vaccinationPLOS ONE, 2017